Skip to main navigation Skip to search Skip to main content

Clinical impact of molecular analysis on thyroid cancer management

  • Volkert B. Wreesmann
  • , Bhuvanesh Singh

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Thyroid cancer constitutes a progressive continuum of disease ranging from indolent well-differentiated carcinomas to aggressive poorly differentiated carcinomas and universally fatal anaplastic carcinomas. The wide divergence in clinical behavior is poorly predicted for by current clinicopathological factors. Moreover, therapeutic armentarium against aggressive thyroid cancers remains limited. Recent studies have identified a range of molecular alterations in thyroid cancers. Clinical implications of the molecular alterations include their utility in diagnostic evaluation, staging and targeted treatment. Continued molecular analysis of thyroid cancers promises to increase our understanding of its biologic behavior and is expected to have further impact on its clinical management
Original languageEnglish
Pages (from-to)1-+
JournalSurgical oncology clinics of North America
Volume17
Issue number1
DOIs
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical impact of molecular analysis on thyroid cancer management'. Together they form a unique fingerprint.

Cite this